Researcher
Rich Miller
Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Background
Richard Miller is Professor of Pathology at the University of Michigan Medical School and director of the Michigan ITP site. He has spent his career on the comparative biology of aging and the rigorous evaluation of candidate longevity interventions in mice.
Key contributions
- One of three PIs running the NIA Interventions Testing Program (with David Harrison at Jackson Lab and Randy Strong at UT San Antonio) — the most rigorous mammalian-lifespan-testing platform in the world.
- Documented lifespan extension by rapamycin, acarbose, 17α-estradiol, NDGA, canagliflozin, and others; documented failure of resveratrol, simvastatin, curcumin, fish oil at typical doses.
- Established the UM-HET3 four-way mouse cross now standard for ITP work.
- Long-time editor of The Journals of Gerontology: Biological Sciences.
Editorial role
Influential voice for scientific rigour and against over-enthusiastic interpretation of weak mouse data in the longevity field.
Related entries
References
- Miller, R. A. et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A 66, 191–201 (2011).